Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...

University of Pittsburgh scientists have independently validated a new blood test platform that can simultaneously measure ...

Study reveals widespread dysregulation of transposable elements (TEs) in aging human brains with Alzheimer's disease, using ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction ...

Loneliness increased the risk for all-cause dementia, Alzheimer’s disease, vascular dementia, and cognitive impairment, ...

Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study ...

In the six months that the test has been available through Mayo Clinic Laboratories, demand has exceeded expectations, a lab ...

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the ...

Collaboration among researchers, businesses, and governments are vital as dementia cases in Africa rise, according to ...

The NIH is funding a University of Oklahoma study on whether dementia patients' end-of-life care aligns with their wishes.

New technologies will radically change the experience of living with and caring for someone with Alzheimer's, says Professor ...